New Nationwide Heparin Recall

New Nationwide Heparin Recall: B. Braun Medical Inc. and FDA notified healthcare professionals of a nationwide recall because testing indicated a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant. The affected lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010. The FDA had advised customers to discontinue use of any of the affected lots and reports any adverse events to the FDA. Certain lots of the popular blood thinner and clot medication Heparin were recalled due to a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant. The affected lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010.

Certain lots of the popular blood thinner and clot medication Heparin were recalled due to a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant. The affected lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010.

This is not the first time that this important medication has had contamination issues. Litigation is ongoing related to prior lots contaminated due to over seas facilities and a lack of quality control. It is unknown at this time whether outsourcing affected these lots.

The product lot numbers, expiration dates, and recall instructions are listed in the Press Release.